

- Title
SJ No 129 - 29 November 2012
HEALTH—CHEMOTHERAPY DRUG
- Database
Senate Journals
- Date
29-11-2012
- Source
Senate
- Parl No.
43
- Number
129
- Page
0
- Status
- System Id
chamber/journals/20121129_SJ129/0017
Previous Fragment Next Fragment
-
Senate Journal No. 129 - 29 November 2012
- 1 MEETING OF SENATE
- 2 ENVIRONMENT PROTECTION AND BIODIVERSITY CONSERVATION AMENDMENT (BIOREGIONAL PLANS) BILL 2011
- 3 RENEWABLE ENERGY (ELECTRICITY) AMENDMENT (EXCESSIVE NOISE FROM WIND FARMS) BILL 2012
- 4 PETITIONS
- 5 NOTICE OF MOTION WITHDRAWN
- 6 SELECTION OF BILLS—STANDING COMMITTEE—REPORT NO. 16 OF 2012
- 7 LEAVE OF ABSENCE
- 8 NATIONAL BROADBAND NETWORK—JOINT STANDING COMMITTEE—LEAVE TO MEET DURING SITTING
- 9 PARLIAMENTARY ZONE—CAPITAL WORKS PROPOSALS—APPROVAL
- 10 LEGAL AND CONSTITUTIONAL AFFAIRS REFERENCES COMMITTEE—PROPOSED REFERENCE
- 11 FOREIGN AFFAIRS—IRAQ—CHRISTIAN ASSYRIANS
- 12 ADMINISTRATION—GOVERNMENT TRANSPARENCY
- 13 HEALTH—NATIONAL ASBESTOS AWARENESS WEEK
- 14 RURAL AND REGIONAL AFFAIRS AND TRANSPORT REFERENCES COMMITTEE—PROPOSED REFERENCE
- 15 FINANCE AND PUBLIC ADMINISTRATION REFERENCES COMMITTEE—REFERENCE
- 16 FOREIGN AFFAIRS—IRAN—HUMAN RIGHTS
- 17 HEALTH—CHEMOTHERAPY DRUG
- 18 COMMITTEES—ADDITIONAL INFORMATION—ESTIMATES
- 19 PUBLICATIONS—STANDING COMMITTEE—22ND REPORT
- 20 REGULATIONS AND ORDINANCES—STANDING COMMITTEE—DOCUMENT
- 21 EDUCATION, EMPLOYMENT AND WORKPLACE RELATIONS REFERENCES COMMITTEE—REPORT—ALLOWANCE PAYMENT SYSTEM
- 22 SENATORS' INTERESTS—STANDING COMMITTEE—REPORT—DEVELOPMENT OF A DRAFT CODE OF CONDUCT FOR SENATORS
- 23 SENATORS' INTERESTS—STANDING COMMITTEE—DOCUMENT
- 24 WATER AMENDMENT (WATER FOR THE ENVIRONMENT SPECIAL ACCOUNT) E BILL 2012
- 25 HOURS OF MEETING AND ROUTINE OF BUSINESS—VARIATION
- 26 WHEAT EXPORT MARKETING AMENDMENT BILL 2012
- 27 QUESTIONS
- 28 MOTION TO TAKE NOTE OF ANSWERS
- 29 WHEAT EXPORT MARKETING AMENDMENT BILL 2012
- 30 TREASURY LEGISLATION AMENDMENT (UNCLAIMED MONEY AND OTHER MEASURES) BILL 2012
- 31 COMMITTEE MEMBERSHIP
- 32 PARLIAMENTARY COMMITTEE REPORTS—PRESIDENT'S REPORT—GOVERNMENT RESPONSES OUTSTANDING
- 33 DEPARTMENT OF THE SENATE—REGISTER OF SENIOR EXECUTIVE OFFICERS' INTERESTS—DOCUMENT
- 34 AUSTRALIAN PARLIAMENTARY DELEGATION TO PAKISTAN—DOCUMENT
- 35 COMMONWEALTH OMBUDSMAN—ACTIVITIES UNDER PART V OF THE AUSTRALIAN FEDERAL POLICE ACT—DOCUMENT
- 36 PRIVACY AMENDMENT (ENHANCING PRIVACY PROTECTION) BILL 2012
- 37 ENVIRONMENT AND COMMUNICATIONS REFERENCES COMMITTEE—GOVERNMENT RESPONSE—ADEQUACY OF PROTECTIONS FOR THE PRIVACY OF AUSTRALIANS ONLINE
- 38 AUSTRALIA'S IMMIGRATION DETENTION NETWORK—JOINT SELECT COMMITTEE—GOVERNMENT RESPONSE—FINAL REPORT
- 39 MARITIME POWERS BILL 2012—EXPLANATORY MEMORANDUM
- 40 DEPARTMENT OF DEFENCE—SPECIAL PURPOSE FLIGHTS—DOCUMENT
- 41 LAW AND JUSTICE— MURRAY DARLING BASIN DRAFT PLAN—LEGAL ADVICE—ORDER FOR PRODUCTION OF DOCUMENTS—DOCUMENT
- 42 DOCUMENTS
- 43 SUPERANNUATION LEGISLATION AMENDMENT (FURTHER MYSUPER AND TRANSPARENCY MEASURES) BILL 2012
- 44 NATIONAL GAMBLING REFORM BILL 2012E NATIONAL GAMBLING REFORM (RELATED MATTERS) BILL (NO. 1) 2012E NATIONAL GAMBLING REFORM (RELATED MATTERS) BILL (NO. 2) 2012
- 45 CUSTOMS AMENDMENT (MALAYSIA-AUSTRALIA FREE TRADE AGREEMENT IMPLEMENTATION AND OTHER MEASURES) BILL 2012E CUSTOMS TARIFF AMENDMENT (MALAYSIA-AUSTRALIA FREE TRADE AGREEMENT IMPLEMENTATION) BILL 2012
- 46 WHEAT EXPORT MARKETING AMENDMENT BILL 2012
- 47 COMMITTEE MEMBERSHIP
- 48 NEXT MEETING OF SENATE
- 49 LEAVE OF ABSENCE
- 50 END OF 2012 SITTINGS—STATEMENT BY PRESIDENT
- 51 ADJOURNMENT
- 52 ATTENDANCE
HEALTH—CHEMOTHERAPY DRUGSenator Xenophon, also on behalf of Senators Fierravanti-Wells and Madigan, pursuant to notice of motion not objected to as a formal motion, moved general business notice of motion no. 1080—That the Senate— (a) notes the concerns of key stakeholders in relation to the price reduction of chemotherapy drug Docetaxel and its potential broader impact on the treatment of cancer patients; (b) calls on the Government to: (i) negotiate with relevant bodies regarding the cost of dispensing chemotherapy drugs, and (ii) ensure that the result of these negotiations will allow pharmacists to continue dispensing the drug, and other chemotherapy drugs, without disrupting patients; (c) welcomes the policy of price disclosure of items on the Pharmaceutical Benefits Scheme; and (d) calls on the Government to ensure that further disruption to patients does not occur. Statement by leave: The Parliamentary Secretary for School Education and Workplace Relations (Senator Collins), by leave, made a statement relating to the motion. Question put and passed. | |